title: Eculizumab inhibits hemolysis in a model of ABO-incompatible red blood cell transfusion.
authors.affiliation: Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN.
authors.forename: Cynthia R
authors.initials: CR
authors.lastname: Fata
authors.affiliation: Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT.
authors.forename: Eric A
authors.initials: EA
authors.lastname: Gehrie
authors.affiliation: Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN. pampee.young@vanderbilt.edu.|Department of Pathology, Tennessee Valley Healthcare System, Nashville, TN. pampee.young@vanderbilt.edu.
authors.forename: Pampee P
authors.initials: PP
authors.lastname: Young
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology*; D001787:Blood Group Incompatibility / Q000097:blood / Q000188:drug therapy*; D017707:Erythrocyte Transfusion; D005260:Female; D006461:Hemolysis / Q000187:drug effects*; D006801:Humans; D008297:Male; D008954:Models, Biological
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C481642:eculizumab